Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New Self-Sampling and digital colposcopy could speed up cervical cancer detection

NCT ID NCT07593066

Diagnosis Sponsor: Pontificia Universidad Catolica de Chile Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

The PRIORITY study is testing a new approach to diagnose cervical cancer earlier by combining self-sampling at home with digital colposcopy and telemedicine. Researchers will enroll 700 women aged 30 to 65 to see if this method is more accurate and faster than current care. The goal is to improve early detection, especially for women who face barriers to regular screening.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could lead to a faster, more accurate way to detect cervical cancer early, especially for women in remote areas.
What could go wrong
This is an observational study, so it won't directly test a new treatment. The results may not apply to all populations or healthcare settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 700 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jun 2026

An estimate. Start dates often move.

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Women aged 30 to 65 years participating in cervical cancer screening programs in participating centers, including both urban and underserved populations. The study aims to reflect real-world conditions, including variability in access to care, geographic barriers, and healthcare system navigation.

Ages

30 to 65 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Women aged 30 to 65 years * Eligible for cervical cancer screening according to national guidelines * Able and willing to provide informed consent * Able to perform self-sampling or attend clinical evaluation if required Exclusion Criteria: * Previous diagnosis of cervical cancer * History of total hysterectomy (removal of the cervix) * Current pregnancy if it precludes study procedures according to clinical judgment * Any medical or social condition that, in the opinion of the investigators, would interfere with participation or follow-up

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cervical cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cervical cancer cervical intraepithelial neoplasia dysplasia of cervix human papilloma virus infection Uterine Cervical Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cervical cancer Cervical intraepithelial neoplasia HPV infection

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    8 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Ancora San Francisco Medical Center UC Christus Health Network

    Santiago, Metropolitan Region, 8150031, Chile

  • Cancer Centre UC-Christus Nuestra Sra de la Esperanza

    Santiago, Metropolitan Region, 8330032, Chile

  • Hospital San Pablo

    Coquimbo, Coquimbo Region, 1781881, Chile

  • Hospital de Talca

    Talca, Maule Region, 3460001, Chile

  • Hospital regional de Coyhaique

    Coyhaique, Aysén, 5951801, Chile

  • San Joaquín Medical Center, UCChristus Health Network

    Santiago, Metropolitan Region, 7820436, Chile

  • San Jorge Medical Center UC-Christus Health Network

    Santiago, Metropolitan Region, 7580153, Chile

  • Santa Lucia Medical Center UC-Christus Health Network

    Santiago, Metropolitan Region, 8331010, Chile

More trials for these conditions

Other studies related to the condition(s) this trial covers.